Categories
Connect with us on LinkedIn
How a 3-Person Team Got to Phase 3 — Without the Overhead
Gameto proves you don’t need a large CRO or a floor of data managers to run complex global...
From Hype to Health: What Sword Health Got Right About Evidence
Sword Health didn’t follow the typical digital health playbook. Instead of rushing to market, they invested early in...
The New Standard in Participant-Centric Trials: What Castor’s 2025 Updates Reveal About the Future of Clinical Research
Explore how Castor’s 2025 updates reduce site burden and boost compliance through scalable, flexible DTP workflows.
Building Biotech: From Science to Scale – Strategic Lessons from the Frontline
Hard truths on scaling biotech: data isn’t enough, CEOs matter, and funding follows story—not science.
Waiver of Consent vs Waiver of Written Consent
One is very common, the other is rarely granted. Learn the key differences between waiver of consent &...
10 FAQs on eConsent
To gain a deeper understanding of eConsent, we have gathered the 10 most frequently asked questions that address...
Don’t Overengineer It: Hybrid Designs Overcome Barriers in DTx Clinical Trials
At DTxEast 2023, Castor joined a panel discussion to answer big questions when designing DTx clinical trials
Preparing Your eConsent Study for IRB Approval
In this blog we cover how eConsent benefits trials and aligns with IRB ethical commitments, how to prepare...
5 steps for patient engagement and better outcomes in decentralized clinical trials
For successful decentralized clinical trials, researchers must encourage patient engagement. Learn 5 steps that modern companies are taking...
Electronic Case Report Forms (eCRFs) in Clinical Trials: Shifting to a Modern Research Paradigm
Castor is shifting the research paradigm for eCRF in clinical trials, transitioning from old, inefficient processes to a...
How to use Python to move RWD into Castor’s Clinical Data Platform
This white paper from Castor explores the importance of choosing an EDC with an API before starting a...
Choosing an EDC with a Robust API for Digital Therapeutics Clinical Trials
This white paper from Castor explores the importance of choosing an EDC with an API before starting a...
Clinical Research in 2035: What can we expect?
Leaders from Castor discuss what changes we can expect in clinical research, technology, and data through the lens...
The future of rare disease research
Each rare disease research breakthrough offers the promise of a longer, better life for patients who otherwise may...
How to Incorporate Remote Technology in Your Next Medical Device Trial
Researchers are looking to incorporate remote technologies into medical device trials for a wide range of device classifications....
How Decentralized Trials Can Support Meaningful Diversity
The Castor team is thrilled to see an increasing emphasis on diversity of race, gender, and even geography...
Digital Therapeutic Cybersecurity: Keeping Participant Data Safe
DTx represent an emerging field of software-driven, evidence-based products intended to “prevent, manage, or treat a medical disease...
How Medical Device Trials Can Benefit from Decentralized Methods
At Castor, we hope to see DCT extend into all trials as we work alongside researchers in the...
Connect with us on LinkedIn
